Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perfluorooctanoic acid inhibits cell proliferation through mitochondrial damage. | Toxicol In Vitro | 2024 | 38513818 | PubTator, text mining | PubMed |
| Urinary liver-type fatty acid-binding protein levels may be associated with the occurrence of acute kidney injury induced by trauma. | Front Med (Lausanne) | 2024 | 38463489 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma LINC01116 Outcompetes T Cells for Linoleic Acid and Accelerates Tumor Progression. | Adv Sci (Weinh) | 2024 | 38460179 | PubTator, text mining | PubMed |
| Significant association of elevated serum galectin-9 levels with the development of non-alcoholic fatty liver disease in patients with rheumatoid arthritis. | Front Med (Lausanne) | 2024 | 38371515 | PubTator, text mining | PubMed |
| Comparison of Urinary Liver Fatty Acid Binding Protein Level and Pathologic Biopsy Findings 1 Year After Kidney Transplantation. | Transplant Proc | 2024 | 38341299 | PubTator, text mining | PubMed |
| Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study. | J Clin Med | 2024 | 38337429 | PubTator, text mining | PubMed |
| A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients. | Int Immunopharmacol | 2024 | 38325047 | PubTator, text mining | PubMed |
| Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma. | BMC Gastroenterol | 2024 | 38302914 | PubTator, text mining | PubMed |
| Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration. | J Cancer Res Clin Oncol | 2024 | 38300311 | PubTator, text mining | PubMed |
| Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein (FABP1) and FABP1 Binding Alters Drug Metabolism. | bioRxiv | 2024 | 38293009 | PubTator, text mining | PubMed |
| Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma. | World J Clin Oncol | 2024 | 38292656 | PubTator, text mining | PubMed |
| Urinary vanin-1, tubular injury, and graft failure in kidney transplant recipients. | Sci Rep | 2024 | 38280883 | PubTator, text mining | PubMed |
| Chemically-defined and scalable culture system for intestinal stem cells derived from human intestinal organoids. | Nat Commun | 2024 | 38280855 | PubTator, text mining | PubMed |
| Single-cell landscape of the cellular microenvironment in three different colonic polyp subtypes in children. | Clin Transl Med | 2024 | 38264936 | PubTator, text mining | PubMed |
| Multiple blood gas variables predict AKI survival in an independent manner. | BMC Nephrol | 2024 | 38262964 | PubTator, text mining | PubMed |
| Effects of high-intensity intermittent exercise versus moderate-intensity continuous exercise on renal hemodynamics assessed by ultrasound echo. | Physiol Rep | 2024 | 38262710 | PubTator, text mining | PubMed |
| Equine Rotavirus A under the One Health Lens: Potential Impacts on Public Health. | Viruses | 2024 | 38257830 | PubTator, text mining | PubMed |
| Histopathological Spectrum and Molecular Characterization of Liver Tumors in the Setting of Fontan-Associated Liver Disease. | Cancers (Basel) | 2024 | 38254797 | PubTator, text mining | PubMed |
| Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury. | Biomolecules | 2024 | 38254682 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink. | Pathogens | 2024 | 38251375 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=12